Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T00:58:44.211Z Has data issue: false hasContentIssue false
  • English
  • Français

Propranolol as a treatment for multiple coronary artery micro-fistulas

Published online by Cambridge University Press:  09 April 2014

María Hernández ,
Juan M. Carretero  and
Fredy Prada
María Hernández
Affiliation:
Department of Pediatrics, Hospital Joan XXIII Tarragona, Tarragona, Spain
Juan M. Carretero*
Affiliation:
Department of Pediatric Cardiology, Hospital Sant Joan de Dèu, Barcelona, Spain
Fredy Prada
Affiliation:
Department of Pediatric Cardiology, Hospital Sant Joan de Dèu, Barcelona, Spain
*
Correspondence to: Dr J. M. Carretero, MD, Department of Cardiology, Sant Joan de Dèu Hospital, Paseo Sant Joan de Dèu, 2, Esplugues 08950, Barcelona, Spain. Tel: +34 695220360; Fax:+34 932532149; E-mail: jcarretero@hsjdbcn.org
Get access Rights & Permissions [Opens in a new window]

Abstract

We present a case of congenital multiple coronary artery–left ventricle micro-fistulas, which were treated with propranolol disappearing within 6 months. She had a malformative syndrome associated with a chromosomal abnormality. The treatment for coronary artery fistula includes surgical ligation and transcatheter closure, but they are not indicated in congenital micro-fistulas. We propose propranolol as a treatment in this type of diffuse fistula.

Keywords

Coronary artery fistulacongenital heart defectspropranolol
Type
Brief Reports
Information
Cardiology in the Young , Volume 25 , Issue 2 , February 2015 , pp. 380 - 383
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Mangukia, CV. Coronary artery fistula. Ann Thorac Surg 2012; 93: 2084–2092.CrossRefGoogle ScholarPubMed
2. Hogeling, M, Adams, S, Wargon, OA. Randomized controlled trial of propanolol for infantile hemagiomas. Pediatrics 2011; 128: 259–265.CrossRefGoogle Scholar
3. Dresios, C, Apostolakis, S, Tzortzis, S, et al. Apical hypertrophic cardiomyopathy associated with multiple coronary artery–left ventricular fistulae: a report of a case and review of the literature. Eur J Echocardiogr 2010; 11: E9.Google ScholarPubMed
4. Duckworth, F, Mukharji, J, Vetrovec, GW. Diffuse coronary artery to left ventricular communications: an unusual cause of demonstrable ischemia. Cathet Cardiovasc Diagn 1987; 13: 133–137.Google ScholarPubMed
5. Storch, CH, Hoeger, PH. Propanalol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269–274.CrossRefGoogle ScholarPubMed
6. Malan, V, Romana, S. Diagnosis of chromosomal abnormalities by array CGH in constitutional pathology: the end of the first-line karyotype. Arch Pediatr 2012; 19: 437–442.CrossRefGoogle ScholarPubMed